• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重后发生严重心血管事件的风险:西班牙EXACOS-CV研究的结果

Risk of severe cardiovascular events following COPD exacerbations: results from the EXACOS-CV study in Spain.

作者信息

Santos Salud, Manito Nicolás, Sánchez-Covisa Joaquín, Hernández Ignacio, Corregidor Carmen, Escudero Luciano, Rhodes Kirsty, Nordon Clementine

机构信息

Servicio de Neumología, Hospital Universitario de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Servicio de Cardiología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

Rev Esp Cardiol (Engl Ed). 2025 Jan;78(2):138-150. doi: 10.1016/j.rec.2024.06.003. Epub 2024 Jun 25.

DOI:10.1016/j.rec.2024.06.003
PMID:38936468
Abstract

INTRODUCTION AND OBJECTIVES

This real-world study-the first of its kind in a Spanish population-aimed to explore severe risk for cardiovascular events and all-cause death following exacerbations in a large cohort of patients with chronic obstructive pulmonary disease (COPD).

METHODS

We included individuals with a COPD diagnosis code between 2014 and 2018 from the BIG-PAC health care claims database. The primary outcome was a composite of a first severe cardiovascular event (acute coronary syndrome, heart failure decompensation, cerebral ischemia, arrhythmia) or all-cause death following inclusion in the cohort. Time-dependent Cox proportional hazards models estimated HRs for associations between exposed time periods (1-7, 8-14, 15-30, 31-180, 181-365, and >365 days) following an exacerbation of any severity, and following moderate or severe exacerbations separately (vs unexposed time before a first exacerbation following cohort inclusion).

RESULTS

During a median follow-up of 3.03 years, 18 901 of 24 393 patients (77.5%) experienced ≥ 1 moderate/severe exacerbation, and 8741 (35.8%) experienced the primary outcome. The risk of a severe cardiovascular event increased following moderate/severe COPD exacerbation onset vs the unexposed period, with rates being most increased during the first 1 to 7 days following exacerbation onset (HR, 10.10; 95%CI, 9.29-10.97) and remaining increased >365 days after exacerbation onset (HR, 1.65; 95%CI, 1.49-1.82).

CONCLUSIONS

The risk of severe cardiovascular events or death increased following moderate/severe exacerbation onset, illustrating the need for proactive multidisciplinary care of patients with COPD to prevent exacerbations and address other cardiovascular risk factors.

摘要

引言与目的

这项现实世界研究是西班牙人群中的首例此类研究,旨在探讨一大群慢性阻塞性肺疾病(COPD)患者病情加重后发生心血管事件和全因死亡的严重风险。

方法

我们纳入了2014年至2018年期间来自BIG-PAC医疗保健索赔数据库且有COPD诊断代码的个体。主要结局是首次发生严重心血管事件(急性冠状动脉综合征、心力衰竭失代偿、脑缺血、心律失常)或纳入队列后全因死亡的复合情况。时间依赖性Cox比例风险模型估计了在任何严重程度的病情加重后暴露时间段(1 - 7天、8 - 14天、15 - 30天、31 - 180天、181 - 365天和>365天)与首次病情加重后中度或重度病情加重分别(与队列纳入后首次病情加重前的未暴露时间段相比)之间关联的风险比(HR)。

结果

在中位随访3.03年期间,24393例患者中有18901例(77.5%)经历了≥1次中度/重度病情加重,8741例(35.8%)出现了主要结局。与未暴露时间段相比,中度/重度COPD病情加重发作后严重心血管事件的风险增加,在病情加重发作后的前1至7天发生率增加最为明显(HR = 10.10;95%置信区间[CI],9.29 - 10.97),在病情加重发作>365天后仍保持增加(HR = 1.65;95%CI,1.49 - 1.82)。

结论

中度/重度病情加重发作后严重心血管事件或死亡的风险增加,这表明需要对COPD患者进行积极的多学科护理,以预防病情加重并处理其他心血管危险因素。

相似文献

1
Risk of severe cardiovascular events following COPD exacerbations: results from the EXACOS-CV study in Spain.慢性阻塞性肺疾病急性加重后发生严重心血管事件的风险:西班牙EXACOS-CV研究的结果
Rev Esp Cardiol (Engl Ed). 2025 Jan;78(2):138-150. doi: 10.1016/j.rec.2024.06.003. Epub 2024 Jun 25.
2
Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan.慢性阻塞性肺疾病加重后发生严重心血管事件的风险增加:日本 EXACOS-CV 研究结果。
Adv Ther. 2024 Aug;41(8):3362-3377. doi: 10.1007/s12325-024-02920-y. Epub 2024 Jul 8.
3
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.慢性阻塞性肺疾病加重后心血管事件的风险:利用荷兰 PHARMO 数据网络的 EXACOS-CV 队列研究结果。
Respir Res. 2023 Nov 21;24(1):293. doi: 10.1186/s12931-023-02601-4.
4
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后长期心血管风险增加。
Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487.
5
Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.COPD 急性加重后死亡和心血管事件的风险:EXACOS-CV 美国研究。
Int J Chron Obstruct Pulmon Dis. 2024 Jan 18;19:225-241. doi: 10.2147/COPD.S438893. eCollection 2024.
6
Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany.阐明 COPD 加重的心肺后果风险:德国 EXACOS-CV 研究的结果。
BMJ Open Respir Res. 2024 Mar 30;11(1):e002153. doi: 10.1136/bmjresp-2023-002153.
7
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies.EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies. EXAcerbations of COPD and their Outcomes on Cardiovascular diseases (EXACOS-CV) 计划:多国家观察性队列研究方案。
BMJ Open. 2023 Apr 26;13(4):e070022. doi: 10.1136/bmjopen-2022-070022.
8
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy.慢性阻塞性肺疾病急性加重后心血管事件:意大利 COPD 加重及其心血管疾病结局研究的结果。
Eur J Intern Med. 2024 Sep;127:97-104. doi: 10.1016/j.ejim.2024.04.021. Epub 2024 May 9.
9
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.慢性阻塞性肺疾病急性加重后非致命性心血管事件的时间风险:一项基于人群的研究。
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
10
Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.COPD 稳定合并心血管疾病患者的加重与严重心血管事件相关:一项全国性基于人群的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 1;18:419-429. doi: 10.2147/COPD.S396790. eCollection 2023.

引用本文的文献

1
Prevalence and Risk Factors of Arrhythmias in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病急性加重患者心律失常的患病率及危险因素:一项系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2025 Sep 3;20:3059-3072. doi: 10.2147/COPD.S545658. eCollection 2025.
2
Delphi Consensus on the Management of COPD Exacerbation Syndrome in Inpatient and Outpatient Settings.住院和门诊环境中慢性阻塞性肺疾病急性加重综合征管理的德尔菲共识
Open Respir Arch. 2025 Jun 24;7(4):100458. doi: 10.1016/j.opresp.2025.100458. eCollection 2025 Oct-Dec.
3
Framework for Exploration of Statistical Heterogeneity in Multi-Database Studies: A Case Study Using EXACOS-CV Studies.
多数据库研究中统计异质性的探索框架:一项使用EXACOS-CV研究的案例分析
Clin Epidemiol. 2025 Jun 14;17:551-565. doi: 10.2147/CLEP.S520168. eCollection 2025.
4
The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies.慢性阻塞性肺疾病急性加重后心血管风险的持续增加:EXACOS-CV研究的荟萃分析
ERJ Open Res. 2025 Jun 16;11(3). doi: 10.1183/23120541.01091-2024. eCollection 2025 May.
5
Hospitalization Predictors in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Post Hoc Study of a Multicentric Retrospective Analysis.慢性阻塞性肺疾病急性加重期的住院预测因素:一项多中心回顾性分析的事后研究
J Clin Med. 2025 Apr 21;14(8):2855. doi: 10.3390/jcm14082855.
6
Chronic Obstructive Pulmonary Disease and COVID-19: The Impact of Hematological Biomarkers on Disease Severity and Outcomes.慢性阻塞性肺疾病与2019冠状病毒病:血液生物标志物对疾病严重程度和预后的影响
J Clin Med. 2025 Apr 17;14(8):2765. doi: 10.3390/jcm14082765.
7
Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study.西班牙接受布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病患者的特征:AURA研究
Int J Chron Obstruct Pulmon Dis. 2025 Apr 9;20:999-1008. doi: 10.2147/COPD.S490227. eCollection 2025.